UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043030 |
|---|---|
| Receipt number | R000049120 |
| Scientific Title | Global Educational Needs Evaluation: Systematic Interprofessional Survey in Cancer Cachexia, a Japanese subset |
| Date of disclosure of the study information | 2021/01/18 |
| Last modified on | 2023/02/25 10:00:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Global Educational Needs Evaluation, a Japanese subset
Acronym
GENESIS-CC in Japan
Scientific Title
Global Educational Needs Evaluation: Systematic Interprofessional Survey in Cancer Cachexia, a Japanese subset
Scientific Title:Acronym
GENESIS-CC in Japan
Region
| Japan | North America | Europe |
Condition
Condition
Malignant tumor
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Pneumology | Hematology and clinical oncology | Surgery in general |
| Gastrointestinal surgery | Hepato-biliary-pancreatic surgery | Chest surgery |
| Breast surgery | Obstetrics and Gynecology | Pediatrics |
| Ophthalmology | Dermatology | Oto-rhino-laryngology |
| Orthopedics | Urology | Radiology |
| Oral surgery | Neurosurgery | Rehabilitation medicine |
| Nursing |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To explore the actual educational needs of healthcare professionals regarding cancer cachexia
Basic objectives2
Others
Basic objectives -Others
International comparison of educational needs for cancer cachexia
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Practice gaps
Key secondary outcomes
The actual situation of healthcare professionals on
1. Information on cancer cachexia
2. Recognition of cancer cachexia
3. Practice cancer cachexia care
4. Education on cancer cachexia
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
All healthcare professionals involved in the screening, diagnosis, and management of cancer, including physicians, nurses, physical therapists, occupational therapists, speech therapists, dietitians, pharmacists, social workers, and licensed psychologists.
Key exclusion criteria
none
Target sample size
2000
Research contact person
Name of lead principal investigator
| 1st name | Hidenori |
| Middle name | |
| Last name | Arai |
Organization
National Center for Geriatrics and Gerontology
Division name
President
Zip code
474-8511
Address
7-430, Morioka-cho, Obu city, Aichi, Japan
TEL
0562-46-2311
harai@ncgg.go.jp
Public contact
Name of contact person
| 1st name | Tateaki |
| Middle name | |
| Last name | Naito |
Organization
Shizuoka Cancer Center
Division name
Division of Thoracic Oncology
Zip code
411-8777
Address
1007, Shimonagakubo, Nagaizumi, Sunto, Shizuoka, Japan
TEL
055-989-5222
Homepage URL
https://www.scchr.jp/index.html
t.naito@scchr.jp
Sponsor or person
Institute
The Society on Sarcopenia, Cachexia and Wasting Disorders
Institute
Department
Personal name
Funding Source
Organization
Pfizer Inc.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Shizuoka Cancer Center
Address
1007, Shimonagakubo, Nagaizumi, Sunto, Shizuoka, Japan
Tel
055-989-5222
t.naito@scchr.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 01 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
1407
Results
Results date posted
Results Delayed
| Delay expected |
Results Delay Reason
under review
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 12 | Month | 31 | Day |
Date of IRB
| 2021 | Year | 01 | Month | 10 | Day |
Anticipated trial start date
| 2021 | Year | 01 | Month | 18 | Day |
Last follow-up date
| 2021 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Distribution method: Society website, newsletters, emails, or social media (including Twitter, Facebook, etc.)
Survey content: A total of 59 questions in the following areas (1) to (5) (anonymous, selective, SurveyMonkey)
(1) Respondent attributes (job title, years of experience, academic society affiliation, etc.), (2) Knowledge of cancer cachexia (definition, diagnosis, treatment, etc.), (3) Actual recognition of cancer cachexia, (4) Actual cancer cachexia care, (5) Actual education of cancer cachexia
Management information
Registered date
| 2021 | Year | 01 | Month | 16 | Day |
Last modified on
| 2023 | Year | 02 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049120
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
